- £198.21bn
- £217.54bn
- $54.07bn
- 85
- 16
- 86
- 71
REG - AstraZeneca PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - IMFINZI SIGNIFICANT PFS - UNRESECTABLE LUNG CANCER <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - AZ updates on tralokinumab trial in severe asthma <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Total Voting Rights <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - DURVALUMAB RECEIVES US FDA ACCELERATED APPROVAL <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Result of AGM <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - AstraZeneca: Q1 2017 Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 4
AnnouncementREG - AstraZeneca PLC - AstraZeneca: Q1 2017 Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 3
AnnouncementREG - AstraZeneca PLC - AstraZeneca: Q1 2017 Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 2
AnnouncementREG - AstraZeneca PLC - AstraZeneca: Q1 2017 Results <Origin Href="QuoteRef">AZN.L</Origin> - Part 1
AnnouncementREG - AstraZeneca PLC - TAGRISSO RECEIVES FULL APPROVAL IN THE EU <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - Circassia Pharma Plc AstraZeneca PLC - Notification of Major Interest in Shares <Origin Href="QuoteRef">AZN.L</Origin> <Origin Href="QuoteRef">CIRCI.L</Origin>
AnnouncementREG - AstraZeneca PLC - Total Voting Rights <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Tagrisso (osimertinib) receives FDA full approval <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - AZ COMPLETES AGREEMENT WITH TERSERA THERAPEUTICS <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - US FDA issues CRL for ZS-9 in hyperkalaemia <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Notice of AGM <Origin Href="QuoteRef">AZN.L</Origin>
Announcement